Search research articles
Contact Us
Filters
Showing results (211-220 of 274) with videos related to
Page
of 28
Sort By:
Blood Cancer Journal
|
October 16, 2025
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans
David E Mery, Guido Tricot, Samer Al Hadidi, et al.
Haematologica
|
August 30, 2023
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma
Lindsay Hammons, Aniko Szabo, Abhishek Janardan, et al.
Blood Cancer Journal
|
March 5, 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Meera Mohan, Jorge Monge, Nishi Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2016
Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants
Yogesh S Jethava, Alan Mitchell, Joshua Epstein, et al.
Blood
|
May 27, 2006
The molecular classification of multiple myeloma
Fenghuang Zhan, Yongsheng Huang, Simona Colla, et al.
Blood
|
April 23, 2013
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma
Saad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.
Blood Cancer Journal
|
February 14, 2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems
Wancheng Guo, Yihao Zhan, David Mery, et al.
Theranostics
|
August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?
Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2007
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications
Ronald Walker, Bart Barlogie, Jeffrey Haessler, et al.
British Journal of Haematology
|
June 27, 2007
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3
Bart Barlogie, Elias Anaissie, Frits van Rhee, et al.
Page
of 28
Search research articles
Search
Showing results (211-220 of 274) with videos related to
Sort By:
Page
of 28
Blood Cancer Journal
|
October 16, 2025
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans
David E Mery, Guido Tricot, Samer Al Hadidi, et al.
Haematologica
|
August 30, 2023
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma
Lindsay Hammons, Aniko Szabo, Abhishek Janardan, et al.
Blood Cancer Journal
|
March 5, 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Meera Mohan, Jorge Monge, Nishi Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2016
Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants
Yogesh S Jethava, Alan Mitchell, Joshua Epstein, et al.
Blood
|
May 27, 2006
The molecular classification of multiple myeloma
Fenghuang Zhan, Yongsheng Huang, Simona Colla, et al.
Blood
|
April 23, 2013
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma
Saad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.
Blood Cancer Journal
|
February 14, 2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems
Wancheng Guo, Yihao Zhan, David Mery, et al.
Theranostics
|
August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?
Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2007
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications
Ronald Walker, Bart Barlogie, Jeffrey Haessler, et al.
British Journal of Haematology
|
June 27, 2007
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3
Bart Barlogie, Elias Anaissie, Frits van Rhee, et al.
Page
of 28